Liver-Directed Therapy in 2026: Redefining the Roles of Y90, cTACE, and Ablation in HCC
Perspectives on patient selection, treatment sequencing, combination strategies, and the growing influence of systemic therapy.
With Nadine Abi-Jaoudeh, MD; Zachary T. Berman, MD; and Ammar Sarwar, MD, FSIR
